海河平原区棉花饲用黑麦复种方式及水肥利用效率分析

2011年10月-2014年10月连续3年在河北省任县安排了定位试验,通过饲用黑麦不同播期与棉花构建几种棉草复种茬口搭配方式,从产量、经济效益、水分利用效率和养分利用效率以及对土壤肥力影响等方面综合分析棉花饲用黑麦复种的可行性及复种方式。结果表明,棉花可与饲用黑麦复种,为降低饲用黑麦对棉花的影响,饲用黑麦可适当推迟到10月20日播种,次年4月底收获,效益可提高5470.1元·hm^-2。棉花饲用黑麦复种与棉花单作相比,平均水分利用率提高16.49%;水分经济利用效率提高56.54%;并且土壤有机质平均增长幅度提高5.71%,土壤含盐量平均降低幅度达到23.72%,土壤改良效果明显;是适用于该区域的高效复种模式。     

高寒草甸植物水分利用效率研究进展

回顾了光照、温度、土壤水分和CO2浓度对高寒草甸植物水分利用效率的影响等方面的研究进展.由于高寒地区太阳辐射强,高寒草甸植物光合作用时间长,光饱和点高,植物光合作用明显表现出对低温的适应性;而适度地提高温度,植物水分利用效率增大;水分胁迫对光合作用的影响可以分为气孔限制和非气孔限制,同时水分胁迫对不同植物水分利用效率的影响不同;高寒草甸植物比低海拔地区植物利用CO2更有效,提高CO2浓度,植物水分利用效率增大.高寒草甸植物水分利用效率研究对于合理构建和恢复高寒草甸生态系统具有重要意义.     

功能性寡糖对锦江黄牛瘤胃发酵及微生物生长效率的影响

本试验旨在研究不同水平的功能性寡糖对锦江黄牛瘤胃发酵及微生物生长效率的影响。采用体外批次培养法,在精粗比为 ２０∶８０的基础饲粮中添加甘露寡糖、果寡糖和大豆寡糖,各组功能性寡糖的添加水平分别为 ０（对照组）、０．８０％、１．００％和 １．２０％。结果表明,饲粮添加功能性寡糖对锦江黄牛瘤胃 ｐＨ无显著影响（Ｐ＞０．０５）,但显著增加培养液挥发性脂肪酸和菌体蛋白浓度（Ｐ＜０．０５）;每日微生物氮产量也有提高的趋势,但差异不显著（Ｐ＞０．０５）。建立微生物生长效率与功能性寡糖添加水平之间的二次曲线模型,当甘露寡糖添加水平为 １．１７％时,微生物生长效率最大,为 ５９．７２ｇ／ｋｇ;当大豆寡糖添加水平为 １．０３％时,微生物生长效率最大,为 ５９．５０ｇ／ｋｇ。综合本试验结果,功能性寡糖的添加水平在 １．００％ ～１．２０％之间更有利于锦江黄牛瘤胃微生物的生长。     

Cardiac troponin I in canine patients with lymphoma and osteosarcoma receiving doxorubicin: comparison with clinical heart disease in a retrospective analysis

The cumulative cardiotoxicity that occurs as a result of doxorubicin chemotherapy is irreversible and can affect both quality and quantity of life for the cancer patient. Cardiac troponin I (cTnI) is a sensitive and specific marker of cardiomyocyte death. The purpose of this retrospective study was to evaluate serum concentrations of cTnI in dogs with lymphoma or osteosarcoma given doxorubicin chemotherapy, and with known cardiac outcome, based on a minimum assessment by physical examination and thoracic radiography. Serum samples were also available for cTnI measurement from seven healthy dogs given intracoronary doxorubicin. Serial serum samples obtained before, during and after doxorubicin chemotherapy showed increased cTnI concentrations in some clinical patients following chemotherapy (P = 0.0083 compared to baseline), but this did not correlate with clinical signs of cardiomyopathy. In dogs that subsequently developed cardiomyopathy however, serum cTnI concentrations were elevated before clinical signs became evident (confirmed with echocardiography).     

Evaluation of cardiac performance of the dog after induction of portal hypertension and gastric ischemia

Objective: To determine changes in hemodynamic and cardiac energetic parameters in dogs after induction of portal hypertension and gastric ischemia. These blood flow alterations are similar to changes seen in splanchnic blood flow in dogs with gastric dilatation volvulus syndrome (GDV). Design: Original experimental study. Setting: Veterinary teaching hospital. Animals: Seven purpose‐bred, intact male dogs. Interventions: Standard midline laparotomy and median sternotomy were performed under general anesthesia. Dogs were instrumented to obtain arterial blood pressure, aortic flow, cardiac chamber pressures, central venous pressure, portal flow, and portal pressure. Colored microsphere technology was used for the determination of myocardial blood flow. Measurements and samples were obtained at baseline, following induction of portal hypertension, and after induction of portal hypertension and gastric ischemia. Measurements and main results: Left ventricular myocardial blood flow was increased from 81.8±20.1 mL/100 g/min at baseline to 127.7±57.2 mL/100 g/min (P=0.02) after induction of portal hypertension and gastric ischemia. Myocardial oxygen consumption increased from 142.2±27.4 J/min/100 g at baseline to 219.1±33.4 J/min/100 g (P=0.003) after induction of portal hypertension and gastric ischemia, but cardiac external work remained unchanged (13.67±6.2 to 13.27±9.6 J/min; P=0.78; power=0.79). Cardiac efficiency decreased from 11.6±6.1% at baseline to 7.6±5.1% (P=0.017) after induction of portal hypertension and gastric ischemia. Conclusions: Transfer of energy within the myocardium was less efficient after induction of portal hypertension and ischemia of the stomach wall. On the basis of these results, alterations in cardiac function associated with GDV may result from deterioration of cardiac efficiency.     

猪霍乱沙门菌菌蜕的制备及免疫保护力研究

为制备猪霍乱沙门菌菌蜕并研究其免疫保护力,本实验克隆噬菌体phiX174裂解基因E,与pBV220连接,构建温控溶菌表达载体,将该载体转入猪霍乱沙门菌TTB1中,制备菌蜕并对其裂解率、安全性以及对小鼠的免疫保护力进行了研究。结果显示：成果克隆了裂解基因E、片段大小274bp,构建了温控溶菌质粒载体pBVE,制备了猪霍乱沙门菌菌蜕,其裂解率最高为99.46%、经冻干灭活残余活菌,安全性试验检测证实其安全后,对小鼠进行了免疫保护试验,其保护率为70%、与弗氏佐剂灭活苗保护率相当、优于甲醛灭活苗。研究结果为猪霍乱沙门菌引发疾病的防治奠定了基础。     

Effects of dobutamine on cardiovascular function and oxygen delivery in standing horses

Dobutamine is routinely used to improve cardiovascular function in anaesthetized horses. However, dobutamine in conscious horses is insufficiently investigated. Ten research horses that were already instrumented for a preceding trial were included into the study. Cardiovascular variables were recorded and blood samples taken after instrumentation (Baseline), before starting dobutamine and after 10 min of dobutamine infusion (2 µg kg⁻¹ min⁻¹). A significant increase in systemic blood pressure, mean pulmonary artery pressure and right atrial pressure, and a decrease in heart rate were observed with dobutamine compared with baseline measurements. Arterial and mixed venous haemoglobin and oxygen content, as well as mixed venous partial pressure of oxygen increased. No significant changes in cardiac output, stroke volume, systemic vascular resistance, arterial partial pressure of oxygen, or oxygen consumption, delivery and extraction ratio were detected. Concluding, dobutamine increased systemic blood pressure without detectable changes in stroke volume, cardiac output or systemic vascular resistance in conscious horses.     

Permanent transvenous cardiac pacing

Transvenous cardiac pacing is a commonly employed treatment for symptomatic bradyarrhythmias in dogs. Medical management of these conditions has not proven to be successful leaving pacing as the only viable alternative. The technique of pacemaker implantation is not difficult, but successful pacemaker therapy requires an understanding of electrophysiology, cardiac fluoroscopic anatomy, pacemaker instrumentation, and programming. Proper patient selection and identification of the underlying rhythm disturbance is essential to a successful clinical outcome. This article discusses the indications, equipment, techniques, complications, and outcome of permanent transvenous cardiac pacing.